CVS — CVS Health Cashflow Statement
0.000.00%
- $82.46bn
- $137.91bn
- $372.81bn
- 71
- 84
- 97
- 98
Annual cashflow statement for CVS Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -83,993 | -94,507 | -101,364 | -117,248 | -146,550 |
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 15,865 | 18,265 | 16,177 | 13,426 | 9,107 |
Capital Expenditures | -2,437 | -2,520 | -2,727 | -3,031 | -2,781 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -3,097 | -2,741 | -2,320 | -17,858 | -4,832 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5,534 | -5,261 | -5,047 | -20,889 | -7,613 |
Financing Cash Flow Items | 337 | -13 | -449 | -382 | -159 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -7,696 | -11,356 | -10,516 | 2,683 | -1,135 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,635 | 1,648 | 614 | -4,780 | 359 |